FDA Approves New Rx For Rare Cancer
A new drug to treat advanced thyroid cancer that has spread to other areas of the body has been approved. The US Food and Drug Administration has approved Cometriq ( cabozantinib ) to treat medullary thyroid cancer.
Thyroid Cancer Rx Adverse Effects
Patients with advanced medullary thyroid cancer ( MTC ) have few treatment options. A medication approved last year has expanded the options. All is not well, though. The drug has adverse effects that can interfere with its use.